UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Decreases Position in HCA Healthcare, Inc. $HCA

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,559,356 shares of the company’s stock after selling 157,059 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.70% of HCA Healthcare worth $728,001,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Korea Investment CORP increased its stake in shares of HCA Healthcare by 10.1% during the 4th quarter. Korea Investment CORP now owns 156,185 shares of the company’s stock worth $72,917,000 after purchasing an additional 14,322 shares during the last quarter. Y Intercept Hong Kong Ltd boosted its holdings in HCA Healthcare by 403.1% in the 4th quarter. Y Intercept Hong Kong Ltd now owns 8,190 shares of the company’s stock worth $3,824,000 after buying an additional 6,562 shares during the period. L1 Capital International Pty Ltd boosted its holdings in HCA Healthcare by 180.5% in the 4th quarter. L1 Capital International Pty Ltd now owns 91,987 shares of the company’s stock worth $42,945,000 after buying an additional 59,188 shares during the period. Sumitomo Life Insurance Co. boosted its holdings in HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after buying an additional 20 shares during the period. Finally, Kane Investment Management Inc. bought a new position in HCA Healthcare in the 4th quarter worth approximately $469,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have commented on the stock. JPMorgan Chase & Co. cut their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Robert W. Baird cut their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a report on Wednesday, April 15th. Oppenheimer cut their price target on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. KeyCorp cut their price target on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a report on Monday, April 27th. Finally, Truist Financial set a $413.00 price target on shares of HCA Healthcare in a report on Thursday, June 4th. Fifteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $506.14.

HCA Healthcare Stock Up 2.3%

HCA Healthcare stock opened at $387.25 on Friday. The company has a market capitalization of $85.91 billion, a PE ratio of 13.32, a P/E/G ratio of 1.20 and a beta of 1.12. The firm has a fifty day simple moving average of $429.60 and a two-hundred day simple moving average of $473.48. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The business’s revenue for the quarter was up 4.3% on a year-over-year basis. During the same period in the prior year, the firm earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s payout ratio is currently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.